Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Miljanka Vuksanovic"'
Autor:
Rosa Pando, Nazarii Kobyliak, Milica Marjanovic Petkovic, Ángel Michael Ortiz Zúñiga, Kevser Onbasi, Hans Prozesky, Neslihan Bascil Tutuncu, Tomasz Skowerski, Kelley Branch, Vladimir Rafalskiy, Fernando Lanas, Dedrick Jordan, Felix Jebasingh, Türkan Paşalı Kilit, Hertzel Gerstein, Miljanka Vuksanovic, Aleksandar Djukic
Publikováno v:
New England Journal of Medicine. 385:896-907
Background: \ud Four glucagon-like peptide-1 (GLP-1) receptor agonists that are structurally similar to human GLP-1 have been shown to reduce the risk of adverse cardiovascular events among persons with type 2 diabetes. The effect of an exendin-based
Autor:
Robert Cuddihy, Rebeca Reyes-Garcia, Eduardo Hernández Salazar, Pawel Bogdanski, Tanja Milicic, Mihaela Vladu, Farida Valeeva, Silvio Buscemi, Veroniek Harbers, Thomas Pieber, Jeppe Gram, Martin Haluzik, Søren Gregersen, Ismet Tamer, Prasad Gunasekaran, Jean O'Connell, Peter Lommer Kristensen, Mustafa Kemal BALCI, Robert Lindsay, Hans Prozesky, JOSE ITALO MOTA, Dilek Gogas Yavuz, Pavel Trachta, Katerina Anderlova, Lise Tarnow, Paramesh S, Miguel Camafort-Babkowski, Selcuk Dagdelen, Shu-Fu Lin, Jarmila Krizova, İSMAİL ENGİN, Marcin Kunecki, Renan Montenegro Junior, Hayriye Esra Ataoglu, IREM DINÇER, John Buse, Jose Sgarbi, Christopher Gilfillan, Tatiana Kiseleva, Henna Cederberg, Sadi Ozdem, Chung-Huei Huang, Miljanka Vuksanovic, Sten Madsbad, Milan Piya, Patrick English, Yu-Yao Huang, Monika Zurawska-Klis, Alan Jaap, Alessandro Mattina, MARIANNA MARANGHI
Publikováno v:
New England Journal of Medicine
Jaap, A 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Marso, S P, Daniels, G H, Brown-Frandsen, K, Kristensen, P, Mann, J F E, Nauck, M A, Nissen, S E, Pocock, S, Poulter, N R, Ravn, L S, Steinberg, W M, Stockner, M, Zinman, B, Bergenstal, R M, Buse, J B, LEADER Steering Committee & Hegedüs, L 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', The New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Jaap, A 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
Marso, S P, Daniels, G H, Brown-Frandsen, K, Kristensen, P, Mann, J F E, Nauck, M A, Nissen, S E, Pocock, S, Poulter, N R, Ravn, L S, Steinberg, W M, Stockner, M, Zinman, B, Bergenstal, R M, Buse, J B, LEADER Steering Committee & Hegedüs, L 2016, ' Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes ', The New England Journal of Medicine, vol. 375, no. 4, pp. 311-322 . https://doi.org/10.1056/NEJMoa1603827
The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. METHODS In this double-blind trial, we randomly assigned patients with type 2 diabetes and hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3beb7f3304e6b754eeb3ba9c143961e
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/417
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/417
Autor:
B. Buric, T. Beljic Zivkovic, M. Andjelic Jelic, Miljanka Vuksanovic, B. Jojic, Jovanka Stojanović, Svetlana Vujovic, N. Milic
Publikováno v:
Climacteric : the journal of the International Menopause Society. 14(6)
Abdominal obesity and metabolic syndrome are known to increase in prevalence from premenopause to postmenopause. Both are well recognized predictors of cardiovascular disease and diabetes in women. Aims The primary objective of this study was to asse
Publikováno v:
Vojnosanitetski Pregled, Vol 65, Iss 9, Pp 692-698 (2008)
Osteoporoza je vazan zdravstveni problem. Prisutan je kod svake trece zene u postmenopauzi i povezuje se sa znacajnim morbiditetom i mortalitetom. Zene sa dijabetesom u postmenopauzi imaju povecan rizik od preloma kuka nego zene koje nisu dijabeticar
Autor:
Miljanka Vuksanovic, T. Beljic Zivkovic, M. Andjelic Jelic, M. Marjanovic, Svetlana Vujovic, Jovanka Stojanović, B. Jojic, N. Milic
Publikováno v:
Maturitas. 71:S46